▶ 調査レポート

抗体薬物複合体の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Antibody-drug Conjugate Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。抗体薬物複合体の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Antibody-drug Conjugate Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D0804-03181資料のイメージです。• レポートコード:D0804-03181
• 出版社/出版日:GlobalInfoResearch / 2020年7月
• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医薬品・治療
• 販売価格(消費税別)
  Single User¥393,240 (USD3,480)▷ お問い合わせ
  Multi User¥589,860 (USD5,220)▷ お問い合わせ
  Corporate User¥786,480 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、抗体薬物複合体の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗体薬物複合体の種類別市場規模(アドセトリス、カドキュラ)、用途別市場規模(乳がん、リンパ腫)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Agensys、Celldex Therapeutics、Concortis Biotherapeutics、Sanofi、Synthon Holding BV
・地域別グローバル市場分析 2015年-2020年
・抗体薬物複合体の北米市場(アメリカ、カナダ、メキシコ)
・抗体薬物複合体のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・抗体薬物複合体のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・抗体薬物複合体の南米市場(ブラジル、アルゼンチン)
・抗体薬物複合体の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:アドセトリス、カドキュラ
・用途別分析:乳がん、リンパ腫
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Antibody-drug Conjugate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Antibody-drug Conjugate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Antibody-drug Conjugate market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Antibody-drug Conjugate market has been segmented into
Adcetris
Kadcyla

By Application, Antibody-drug Conjugate has been segmented into:
Breast Cancer
Lymphoma

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antibody-drug Conjugate market presented in the report. This section sheds light on the sales growth of different regional and country-level Antibody-drug Conjugate markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antibody-drug Conjugate market.

The report offers in-depth assessment of the growth and other aspects of the Antibody-drug Conjugate market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Antibody-drug Conjugate Market Share Analysis
Antibody-drug Conjugate competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antibody-drug Conjugate sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antibody-drug Conjugate sales, revenue and market share for each player covered in this report.

The major players covered in Antibody-drug Conjugate are:
Agensys
Celldex Therapeutics
Concortis Biotherapeutics
Sanofi
Synthon Holding BV

Among other players domestic and global, Antibody-drug Conjugate market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody-drug Conjugate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibody-drug Conjugate, with price, sales, revenue and global market share of Antibody-drug Conjugate in 2018 and 2019.
Chapter 3, the Antibody-drug Conjugate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody-drug Conjugate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Antibody-drug Conjugate market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Antibody-drug Conjugate sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Antibody-drug Conjugate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibody-drug Conjugate Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibody-drug Conjugate Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Overview of Global Antibody-drug Conjugate Market
1.4.1 Global Antibody-drug Conjugate Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Agensys
2.1.1 Agensys Details
2.1.2 Agensys Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Agensys SWOT Analysis
2.1.4 Agensys Product and Services
2.1.5 Agensys Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celldex Therapeutics
2.2.1 Celldex Therapeutics Details
2.2.2 Celldex Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Celldex Therapeutics SWOT Analysis
2.2.4 Celldex Therapeutics Product and Services
2.2.5 Celldex Therapeutics Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Concortis Biotherapeutics
2.3.1 Concortis Biotherapeutics Details
2.3.2 Concortis Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Concortis Biotherapeutics SWOT Analysis
2.3.4 Concortis Biotherapeutics Product and Services
2.3.5 Concortis Biotherapeutics Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Synthon Holding BV
2.5.1 Synthon Holding BV Details
2.5.2 Synthon Holding BV Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Synthon Holding BV SWOT Analysis
2.5.4 Synthon Holding BV Product and Services
2.5.5 Synthon Holding BV Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antibody-drug Conjugate Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antibody-drug Conjugate Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antibody-drug Conjugate Manufacturer Market Share in 2019
3.3.2 Top 6 Antibody-drug Conjugate Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antibody-drug Conjugate Sales, Revenue and Market Share by Regions
4.1.1 Global Antibody-drug Conjugate Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antibody-drug Conjugate Revenue and Market Share by Regions (2015-2020)
4.2 North America Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
4.3 Europe Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
4.5 South America Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antibody-drug Conjugate Sales, Revenue and Market Share by Country
5.1.1 North America Antibody-drug Conjugate Sales and Market Share by Country (2015-2020)
5.1.2 North America Antibody-drug Conjugate Revenue and Market Share by Country (2015-2020)
5.2 United States Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
5.3 Canada Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
5.4 Mexico Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antibody-drug Conjugate Sales, Revenue and Market Share by Country
6.1.1 Europe Antibody-drug Conjugate Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antibody-drug Conjugate Revenue and Market Share by Country (2015-2020)
6.2 Germany Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
6.3 UK Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
6.4 France Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
6.5 Russia Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
6.6 Italy Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antibody-drug Conjugate Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antibody-drug Conjugate Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antibody-drug Conjugate Revenue and Market Share by Regions (2015-2020)
7.2 China Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
7.3 Japan Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
7.4 Korea Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
7.5 India Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
7.7 Australia Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antibody-drug Conjugate Sales, Revenue and Market Share by Country
8.1.1 South America Antibody-drug Conjugate Sales and Market Share by Country (2015-2020)
8.1.2 South America Antibody-drug Conjugate Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
8.3 Argentina Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antibody-drug Conjugate Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antibody-drug Conjugate Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antibody-drug Conjugate Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
9.3 Turkey Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
9.4 Egypt Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
9.5 South Africa Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antibody-drug Conjugate Sales and Market Share by Type (2015-2020)
10.2 Global Antibody-drug Conjugate Revenue and Market Share by Type (2015-2020)
10.3 Global Antibody-drug Conjugate Price by Type (2015-2020)
11 Global Antibody-drug Conjugate Market Segment by Application
11.1 Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
11.2 Global Antibody-drug Conjugate Revenue Market Share by Application (2015-2020)
11.3 Global Antibody-drug Conjugate Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antibody-drug Conjugate Sales, Revenue and Growth Rate (2021-2025)
12.2 Antibody-drug Conjugate Market Forecast by Regions (2021-2025)
12.2.1 North America Antibody-drug Conjugate Market Forecast (2021-2025)
12.2.2 Europe Antibody-drug Conjugate Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antibody-drug Conjugate Market Forecast (2021-2025)
12.2.4 South America Antibody-drug Conjugate Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antibody-drug Conjugate Market Forecast (2021-2025)
12.3 Antibody-drug Conjugate Market Forecast by Type (2021-2025)
12.3.1 Global Antibody-drug Conjugate Sales Forecast by Type (2021-2025)
12.3.2 Global Antibody-drug Conjugate Market Share Forecast by Type (2021-2025)
12.4 Antibody-drug Conjugate Market Forecast by Application (2021-2025)
12.4.1 Global Antibody-drug Conjugate Sales Forecast by Application (2021-2025)
12.4.2 Global Antibody-drug Conjugate Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Antibody-drug Conjugate Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antibody-drug Conjugate by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antibody-drug Conjugate Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Agensys Basic Information, Manufacturing Base and Competitors
Table 8. Agensys Antibody-drug Conjugate Major Business
Table 9. Agensys Antibody-drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 10. Agensys SWOT Analysis
Table 11. Agensys Antibody-drug Conjugate Product and Services
Table 12. Agensys Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 14. Celldex Therapeutics Antibody-drug Conjugate Major Business
Table 15. Celldex Therapeutics Antibody-drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 16. Celldex Therapeutics SWOT Analysis
Table 17. Celldex Therapeutics Antibody-drug Conjugate Product and Services
Table 18. Celldex Therapeutics Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Concortis Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Concortis Biotherapeutics Antibody-drug Conjugate Major Business
Table 21. Concortis Biotherapeutics Antibody-drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 22. Concortis Biotherapeutics SWOT Analysis
Table 23. Concortis Biotherapeutics Antibody-drug Conjugate Product and Services
Table 24. Concortis Biotherapeutics Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sanofi Basic Information, Manufacturing Base and Competitors
Table 26. Sanofi Antibody-drug Conjugate Major Business
Table 27. Sanofi Antibody-drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 28. Sanofi SWOT Analysis
Table 29. Sanofi Antibody-drug Conjugate Product and Services
Table 30. Sanofi Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Synthon Holding BV Basic Information, Manufacturing Base and Competitors
Table 32. Synthon Holding BV Antibody-drug Conjugate Major Business
Table 33. Synthon Holding BV Antibody-drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 34. Synthon Holding BV SWOT Analysis
Table 35. Synthon Holding BV Antibody-drug Conjugate Product and Services
Table 36. Synthon Holding BV Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Antibody-drug Conjugate Sales by Manufacturer (2018-2019) (K Units)
Table 38. Global Antibody-drug Conjugate Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Antibody-drug Conjugate Sales by Regions (2015-2020) (K Units)
Table 40. Global Antibody-drug Conjugate Sales Market Share by Regions (2015-2020)
Table 41. Global Antibody-drug Conjugate Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Antibody-drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 43. North America Antibody-drug Conjugate Sales Market Share by Countries (2015-2020)
Table 44. North America Antibody-drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Antibody-drug Conjugate Revenue Market Share by Countries (2015-2020)
Table 46. Europe Antibody-drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 47. Europe Antibody-drug Conjugate Sales Market Share by Countries (2015-2020)
Table 48. Europe Antibody-drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Antibody-drug Conjugate Sales by Regions (2015-2020) (K Units)
Table 50. Asia-Pacific Antibody-drug Conjugate Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Antibody-drug Conjugate Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Antibody-drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 53. South America Antibody-drug Conjugate Sales Market Share by Countries (2015-2020)
Table 54. South America Antibody-drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Antibody-drug Conjugate Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Antibody-drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Antibody-drug Conjugate Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Antibody-drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Antibody-drug Conjugate Revenue Market Share by Countries (2015-2020)
Table 60. Global Antibody-drug Conjugate Sales by Type (2015-2020) (K Units)
Table 61. Global Antibody-drug Conjugate Sales Share by Type (2015-2020)
Table 62. Global Antibody-drug Conjugate Revenue by Type (2015-2020) (USD Million)
Table 63. Global Antibody-drug Conjugate Revenue Share by Type (2015-2020)
Table 64. Global Antibody-drug Conjugate Sales by Application (2015-2020) (K Units)
Table 65. Global Antibody-drug Conjugate Sales Share by Application (2015-2020)
Table 66. Global Antibody-drug Conjugate Sales Forecast by Regions (2021-2025) (K Units)
Table 67. Global Antibody-drug Conjugate Market Share Forecast by Regions (2021-2025)
Table 68. Global Antibody-drug Conjugate Sales Forecast by Type (2021-2025) (K Units)
Table 69. Global Antibody-drug Conjugate Market Share Forecast by Type (2021-2025)
Table 70. Global Antibody-drug Conjugate Sales Forecast by Application (2021-2025)
Table 71. Global Antibody-drug Conjugate Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Antibody-drug Conjugate Picture
Figure 2. Global Sales Market Share of Antibody-drug Conjugate by Type in 2019
Figure 3. Adcetris Picture
Figure 4. Kadcyla Picture
Figure 5. Antibody-drug Conjugate Sales Market Share by Application in 2018
Figure 6. Breast Cancer Picture
Figure 7. Lymphoma Picture
Figure 8. Global Antibody-drug Conjugate Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Antibody-drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Antibody-drug Conjugate Sales Market Share by Manufacturer in 2019
Figure 29. Global Antibody-drug Conjugate Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Antibody-drug Conjugate Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Antibody-drug Conjugate Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Antibody-drug Conjugate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Antibody-drug Conjugate Revenue Market Share by Regions (2015-2020)
Figure 36. Global Antibody-drug Conjugate Revenue Market Share by Regions in 2018
Figure 37. North America Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
Figure 38. Europe Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
Figure 40. South America Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Antibody-drug Conjugate Sales and Growth Rate (2015-2020)
Figure 42. North America Antibody-drug Conjugate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Antibody-drug Conjugate Sales Market Share by Countries (2015-2020)
Figure 44. North America Antibody-drug Conjugate Sales Market Share by Countries in 2018
Figure 45. North America Antibody-drug Conjugate Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Antibody-drug Conjugate Revenue Market Share by Countries in 2018
Figure 47. United States Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Antibody-drug Conjugate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Antibody-drug Conjugate Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Antibody-drug Conjugate Revenue Market Share by Countries in 2019
Figure 53. Germany Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Antibody-drug Conjugate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Antibody-drug Conjugate Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Antibody-drug Conjugate Revenue Market Share by Regions 2019
Figure 61. China Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Antibody-drug Conjugate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Antibody-drug Conjugate Sales Market Share by Countries in 2019
Figure 68. South America Antibody-drug Conjugate Revenue Market Share by Countries in 2019
Figure 69. Brazil Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Antibody-drug Conjugate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Antibody-drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Antibody-drug Conjugate Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Antibody-drug Conjugate Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Antibody-drug Conjugate Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Antibody-drug Conjugate Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Antibody-drug Conjugate Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Antibody-drug Conjugate Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Antibody-drug Conjugate Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel